Proactive Hf II
Posted Date: Mar 5, 2025
- Investigator: Vladimir Cotarlan
- Specialties:
- Type of Study: Device
The PROACTIVE-HF-2 trial aims to evaluate the safety and efficacy of the Cordella™ Pulmonary Artery Sensor System (SEE VIDEO LINK BELOW) in patients with NYHA Class II-III heart failure. Pulmonary artery pressure data may be very helpful for heart failure doctors to monitor and manage patients (avoiding HF hospitalizations). The primary outcomes focus on heart failure events, hospitalizations, and device safety.
Criteria:
Diagnosis And Treatment Of Heart Failure (Regardless Of Lvef) For =3 Months
Keywords:
Pulmonary Artey (Pa) Sensor For Heart Failure Management
For More Information:
Harshada More
5135584739
morehp@ucmail.uc.edu